Why Is Study Build Still Taking So Long?

The Tufts Center for the Study of Drug Development released its 2017 eClinical Landscape Study last month, and among the results is a troubling statistic: Companies conducting clinical trials are taking an average of 68 days to build their studies, with 77% of survey respondents reporting problems entering data into their electronic data capture (EDC) solution. This comes at a…

Medrio Has a New Look
A sleek image for savvy EDC users

  Medrio has evolved a great deal – and so has our image. Recent upgrades and innovations have unlocked new capabilities for our customers and enhanced the speed, intuitiveness, and efficiency that define their experience with our software. It was time to update our image to reflect the savvy and confident work our users perform every day. Our new look…

The Ultimate EDC Buyer’s Guide: Fundamentals

From self-driving cars to cancer-killing nanobots, the past decade has taken huge leaps in technological advancement, moving us closer to a world our predecessors never imagined. In the same timeframe, clinical trials have become more diverse, and the economic landscape for pharmaceuticals necessitates quicker trial timelines. These pressures have prompted an increased need for electronic data capture (EDC) systems that…

Monthly News Roundup: October 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

What EDC Means at the End of the Day

Shorter timelines, budget savings, easier data management—these are proven benefits of electronic data capture (EDC) for all phases of clinical research. Yet by continuing to use paper-based data capture, as of 2015, more than half of all new clinical trials were missing out on those benefits. That’s unfortunate – but what’s even more unfortunate is that the cost- and time-savings…

What Are the eClinical Implications of the New EU Data Regulation?

A recent article in Clinical Leader outlined concerns about Pharma’s ability to comply with the new EU Data Protection Regulation set to go into effect in May 2018. Indeed, companies doing business in the European Union will have major regulatory changes to contend with, including: Increased territorial scope, which includes where data is processed and stored Increased penalties, which can…

How a Data Management Challenge Becomes a Success Story

Clinical trials are susceptible to all kinds of unforeseen changes: protocol amendments, patient attrition – even a mid-study switch to a new EDC. This was the challenge the research consultants at Study Builders faced after the EDC originally selected by their study sponsor fell short of meeting their needs. In the midst of a time-sensitive Phase 0 study, the decision…

Immunotherapy Research: The Ups and Downs

Nearly two years after we first posted about it, immunotherapy remains one of the biggest buzz generators in clinical research and drug development. This is no surprise – the industry seems to truly believe in the potential of immunotherapy to revolutionize cancer treatment, and sees in it a largely untapped market full of territory yet to be claimed. As a…

Monthly News Roundup: August 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

3 Reasons Cybersecurity Has Become a Top Concern in Clinical Research

The intersection of technology and healthcare has major implications, ranging from encouraging to ominous, for innumerable interested parties. Technological innovators and enthusiastic adoptees tout the potential for technology to improve care and accelerate the development of new treatments and even cures – and they’re not wrong to do so. Part of this, however, is the unavoidable reality that the good…

What Can eSource Do for Patient Engagement?

Modern eClinical tools like eSource-equipped tablet apps are great for site staff and other clinical researchers. How can they help cater to the needs and priorities of clinical trial patients as well? Our infographic offers some insight. Thanks for reading! If you enjoyed this post, we invite you to check out an article we published in International Clinical Trials exploring…

Addressing Clinical Trial Infrastructure Challenges

The last several years have seen a number of high-profile disease outbreaks across the developing world. Ebola struck three West African nations in 2014, mobilizing the World Health Organization and bringing doctors from around the world to the affected areas. The following year, the Zika virus spread throughout major portions of Latin America, with significant impact reaching as far north…

Monthly News Roundup: July 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

3 Considerations as Clinical Trials Go Global

Ask an economist to name the most defining business trend of the 21st Century, and there’s a strong chance the answer will be globalization. Nations and regions are becoming increasingly intertwined through trade and outsourcing. Clinical research is no exception to this trend. Multi-country clinical trials have risen in recent years, and new regions have emerged as today’s most promising…

Monthly News Roundup: June 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

The Benefits of Integration-Ready eClinical

The growing complexity of clinical research has been met, in tandem, by an explosion of eClinical tools enabling researchers to manage that complexity. Electronic data capture (EDC) has optimized data management. Clinical trial management, a sprawling undertaking, is reined in by CTMS. Trial master files (TMF) have gone electronic. As a player in the eClinical market, Medrio is, of course,…

Monthly News Roundup: May 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

The Advantages of CRO-EDC Unity

There’s something endearing about businesses with regular customers. Personal touches, like the business knowing, by heart, things like a customer’s first name and regular order, soften the colder, more transactional nature of their relationship. Ask someone for an example of a type of business that has relationships like these, and she’ll likely cite some neighborhood-oriented establishment, like a restaurant or…

Monthly News Roundup: April 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

How Adaptive Trial-Friendly EDC Benefits Oncology

Adaptive clinical trial design in oncology research represents an intersection of two major industry trends. One of these is the current prevalence of cancer clinical trials. Last year, Clinical Leader cited a GBI Research report that declared oncology the largest therapeutic area in the pharmaceutical industry pipeline. And the promise of immunotherapy continues to galvanize investigations into new cancer treatments.…

Assessing eClinical Tools for Complex Clinical Trials

It’s a time of great evolution for clinical research. Recent years have seen a major expansion in the size and scope of industry operations. It’s increasingly common for clinical trials to cross borders, oceans, and continents.1 Studies and datasets are bigger, and protocols are more complex.2 All of this makes for a more intricate research environment than previous generations of…

Paper in Clinical Trials: No Trivial Problem

When it comes to data management in clinical trials, paper is not just an inconvenience – it’s a liability. The advent of eClinical technology is not driven solely by the discomfort of working in an office full of stacks of paper. Rather, the eClinical revolution is about data security, timelines, and budgets. The ability of CROs to meet their sponsors’…

Monthly News Roundup: March 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

3 Ways to Avoid the Hidden Costs of EDC Training and Support

It has now been several decades since EDC was first introduced as a tool for data management in clinical trials. In that time, boosted by continuous developments and enhancements, the technology has grown from a somewhat esoteric alternative to paper to a standard considered essential throughout most of the industry. Without thorough and comprehensive training and support resources, though, it…

Saving Time with an Efficient EDC Interface

Over the years, the clinical research industry has developed various methods for accessing crucial time savings. Much has been published, for example, on strategies for enhancing patient recruitment, a process that is notoriously vulnerable to delays. EDC, of course, is another major source of these savings. Range checks, for example, allow users to correct errors immediately; once data is transferred…

What Does the Chan Zuckerberg Biohub Mean for EDC?

Medical research has seen a great deal of high-profile philanthropic investment in recent years. Last year, for example, tech billionaire Sean Parker made a $250 million donation to further the development of immunotherapy. Most recently, the Chan Zuckerberg Biohub has made headlines by announcing plans to invest $3 billion in new research over the next 10 years. The investment is…

eSource from the Site Perspective

With the necessary technology and the support of the FDA in place, the eSource revolution is charging forward. Researchers are marveling at the efficiencies eSource creates as its adoption becomes more widespread. While one may expect that a new, groundbreaking technology will initially be met with some resistance from the industry it affects, eSource has already proved highly effective in…

Monthly News Roundup: February 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

How ARG Used an API Integration to Meet a Challenge Head-On

One of our favorite things to see, here at Medrio, is a customer combining our eClinical offerings with their own savvy and ingenuity to enhance their operations and overcome challenges. So when Atlantic Research Group, a CRO and longtime Medrio customer, used our application programming interface (API) to integrate Medrio’s EDC with the interactive response technology (IRT) solution provided by…

5 Ways EDC Reports can Protect your Timelines

The adage “time is money” is as pertinent to clinical research as to any other corner of the business world. The longer a study drags on, the bigger its price tag becomes. Study timelines can be a source of much anxiety for researchers, creating the markets for time-saving innovations like EDC, eSource, and risk-based monitoring. Recent trends are not easing…

eSource PRO: A Phase I Patient Engagement Tool

A major driver of patient recruitment hurdles in Phase I clinical trials could be described as the perceived distance between researchers and subjects. Researchers can appear only interested in mining patients for data, unconcerned with any health risks posed by a compound whose safety profile has yet to be determined. This perception is not-so-affectionately referred to as the “guinea pig…

Tackling Today’s Data Security Demands

Across our society, technology is delivering enhancements and efficiencies to our day-to-day lives at an exponential rate. It has also, however, brought challenges, as regulations designed to establish ethical standards for the use of that technology have struggled to keep up with the pace of innovation. An article in MIT Technology Review notes how this challenge has manifested in areas…

Monthly News Roundup: January 2017

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

A Day in the Life of a Clinical Research Associate

It’s another busy day at work for Carrie the Clinical Research Associate. She’s got data to review, reports to write, and lots of other important tasks on her agenda. Luckily, she’s got Medrio supporting the studies she works with and making her job more convenient. Let’s shadow Carrie at her workplace to get a sense of a typical day for…

What Does Immunotherapy Mean for Trial Design?

It has now been a year since we first posted about immunotherapy on this blog, and several years since the first FDA approval of an immunotherapy treatment for cancer. For anyone paying attention, it’s difficult to avoid the conclusion that immunotherapy is one of today’s hottest topics not only in oncology, but in healthcare at large. Still, the treatment has…

3 Early Obstacles in Phase I, and How to Address Them

Anyone with an involvement or interest in clinical research is likely to be aware of the challenges sponsors face in getting their compounds approved by the FDA. The low rates at which drugs make it all the way through the research process is a favorite topic of blogs and journalistic outlets covering clinical research. Many of the drugs that fall…

Making EDC Accessible to Everyone

Electronic data capture for clinical trials is a multi-billion-dollar industry1 that has brought demonstrable benefits to all phases of clinical research. Still, the portion of clinical trials collecting and managing their data on paper is too large to ignore. As recently as 2015, Open Health News reported that less than half of all new clinical trials were using EDC. And…

Monthly News Roundup: December 2016

Welcome to the Medrio Monthly News Roundup, in which we brief you on a sample of events and developments taking place around the industry. This recurring update functions on popular demand – the stories in this post come from the articles in our social media feeds that garnered the most attention from our readers and followers. Your likes, clicks, and…

How to Keep Headaches Small as Phase I Trials Get Big

Statistics suggest that Phase I clinical trials, while by no means free of challenges, are more manageable than later phases. They tend to take less time and cost less money; the drugs they test have a comfortable 70% chance of moving on to the next phase.1 These figures are a reprieve from some of the realities that make Phase I…

Addressing Safety in Phase I

The purpose of a Phase I trial is to test a new drug or treatment on human subjects for the first time in order to determine its safety, evaluate side effects, and ascertain the correct dosage level. It is important to ensure that each drug or device being tested is safe before moving forward with the next phase. Unfortunately, it…

Recent Posts